SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

Q9NTG7 (SIR3_HUMAN) Homo sapiens (Human)

NAD-dependent protein deacetylase sirtuin-3, mitochondrial UniProtKBInterProSTRINGInteractive Modelling

399 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

42 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of SIRT3 in complex with H4K16la peptide Heteromer
P62805;
121-395
100.0ZN;2OP;
Crystal structure of human Sirt3 in complex with an acetylated HIV1 Tat-46-54 substrate peptide Heteromer
P12506;
121-394
100ZN;
Crystal Structure of human SIRT3 with acetyl-lysine AceCS2 peptide Heteromer
Q9NUB1;
121-394
100ZN;SO4;BCT;GOL;
Crystal Structure of SIRT3 with a H3K9 Peptide Containing a Myristoyl Lysine Heteromer
Q6NXT2;
121-394
100ZN;
Crystal Structure of SIRT3 in complex with H3K9bhb peptide Heteromer
V9H1G0;
122-395
100ZN;
Crystal structure of human Sirt3 in complex with an inhibiting HIV1 Tat-37-59 peptide Heteromer
P12506;
122-395
100ZN;
CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THIOALKYLIMIDATE FORMED FROM THIO-ACETYL-LYSINE AC… Heteromer
Q9NUB1;
121-394
100ZN;CL;PEG;SO4;EDO;
Crystal Structure of Human SIRT3 with ADPR bound to the AceCS2 peptide containing a thioacetyl lysi… Heteromer
Q9NUB1;
121-394
100ZN;SO4;CO3;
Crystal Structure of Human SIRT3 in Complex with a Palmitoyl H3K9 Peptide Heteromer
Q6NXT2;
121-394
100PLM;ZN;
Crystal Structure of Human SIRT3 with AceCS2 peptide Heteromer
Q9NUB1;
121-394
100SO4;ZN;
Crystal structure of SIRT3 bound to a leucylated AceCS2 Heteromer
Q9NUB1;
121-394
100ZN;LEU;LYS;
Crystal structure of human Sirt3 in complex with a fragment of the human AROS protein Heteromer
Q86WX3;
121-394
100ZN;
Human SIRT3 Recognizing CCNE2K348la peptide Heteromer
O96020;
122-395
100ZN;IMD;
Crystal Structure of SIRT3 in complex with H3K4bhb peptide Heteromer
V9H1G0;
122-394
100ZN;GOL;SO4;CIT;
Complex of human Sirt3 with Bromo-Resveratrol and ACS2 peptide Heteromer
Q9NUB1;
122-394
100.0BVB;ZN;
CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH NATIVE ALKYLIMIDATE FORMED FROM ACETYL-LYSINE ACS2… Heteromer
Q9NUB1;
122-394
100EDO;GOL;SO4;PEG;ZN;XYQ;
CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THIOALKYLIMIDATE FORMED FROM THIO-ACETYL-LYSINE AC… Heteromer
Q9NUB1;
122-394
100ZN;EDO;
Crystal Structure of SIRT3 in complex with H4K16bhb peptide Heteromer
P62805;
122-394
100.0ZN;
Crystal structure of SIRT3 in complex with H3K23la peptide Heteromer
P68431;
122-391
100GOL;EDO;ZN;2OP;
Crystal structure of SIRT3 in complex with acetyl p53 peptide coupled with 4-amino-7-methylcoumarin Heteromer
P04637;
122-391
100.0ZN;
Human SIRT3 in complex with halistanol sulfate Heteromer
Q9NUB1;
123-392
100.0ZN;8QF;
14-3-3 sigma sirtuin-3 phospho-peptide complex Heteromer
P31947;
99-108
100MG;CA;CL;
Human SIRT3 bound to p53-AMC peptide and Honokiolmonomer121-394
100.0ZN;Y4T;
Crystal Structure of human SIRT3 with ELT inhibitor 11c [N-{2-[1-(6-carbamoylthieno[3,2-d]pyrimidin…monomer121-394
100ZN;1NQ;
Crystal Structure of human SIRT3 with ELT inhibitor 3 [14-(4-{2-[(methylsulfonyl)amino]ethyl}piperi…monomer120-393
100ZN;1NS;GOL;NA;
Crystal Structure of human SIRT3 with ELT inhibitor 28 [4-(4-{2-[(2,2-dimethylpropanoyl)amino]ethyl…monomer120-393
100ZN;1NR;
Human SIRT3 bound to Ac-ACS peptide and Carba-NADmonomer122-395
100CNA;SO4;ZN;GOL;
Human SIRT3 Recognizing H3K4crmonomer121-394
100.0ZN;CRD;
Human SIRT3 co-crystallized with ligands, including p53-AMC peptide and Carba-NADmonomer122-394
100.0CNA;ZN;
CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND ADP-RIBOSEmonomer122-394
100OCZ;AR6;ZN;
Crystal structure of human SIRT3 in complex with compound (2-butylbenzofuran-3-yl)(4-(2-(diethylami…monomer122-394
100.0ZN;BBI;
Human SIRT3 bound to p53-AMC peptide, Carba-NAD, and Honokiolmonomer121-393
100.0ZN;CNA;
Crystal Structure of Human SIRT3monomer122-394
100ZN;PGE;
Structure of human SIRT3 in complex with SRT1720 inhibitormonomer122-394
100CNA;SR7;ZN;
Structure of human SIRT3 in complex with ADP-ribosemonomer121-392
100ZN;NA;AR6;OP2;
CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND 2'-O-ACETYL-ADP-RIBOSEmonomer121-392
100OCZ;OAD;ZN;NA;CL;
Complex of human Sirt3 with Bromo-Resveratrol and Fluor-De-Lys peptidemonomer122-393
100.0ZN;BVB;IPA;GOL;
Crystal structure of human Sirt3 in complex with Fluor-de-Lys peptide and piceatannolmonomer122-393
100.0ZN;PIT;IPA;
Crystal structure of human Sirt3 at an improved resolutionmonomer121-391
100ZN;PEG;MG;
Crystal structure of hSIRT3 in complex with a specific agonist Amiodarone hydrochloridemonomer121-391
100ZN;MG;BBI;NAD;MCM;
Crystal structure of human sirtuin 3 fragment (residues 118-399) bound to intermediates from reacti…monomer122-391
100ZN;5IA;
CRYSTAL STRUCTURE OF SIRT3 IN COMPLEX WITH THE INHIBITOR EX-527 AND NADmonomer122-391
100NAD;APR;OCZ;ZN;NO3;GOL;NA;CL;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8bbk.1.Amonomer0.87121-394
ZN;100.00

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28ccw.1.Amonomer0.891-252
SER;ZN;100.00